Metformin

insulin ; Homo sapiens







1675 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1601 7926420 [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy]. 1993 Sep-Oct 1
1602 8112499 Metformin--an update. 1993 Nov 1
1603 8158383 Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. 1993 Dec 1
1604 8222336 Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effects of metformin. 1993 Sep 1
1605 8339856 Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects. 1993 Mar-Apr 1
1606 8387542 Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. 1993 May 2
1607 8412779 The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. 1993 Sep 2
1608 8453955 Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 1993 6
1609 8462390 Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. 1993 Apr 1
1610 8475636 [Combination therapy of oral antidiabetic drugs with insulin]. 1993 Mar 1
1611 1505458 Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. 1992 Sep 1
1612 1523352 Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes. 1992 Jan-Mar 2
1613 1543016 Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro. 1992 Feb 7
1614 1551495 Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. 1992 Mar 5
1615 1569149 Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. 1992 May 1
1616 1583082 Metformin and blood pressure. 1992 Apr 3
1617 1600835 Biguanides and NIDDM. 1992 Jun 2
1618 1752350 Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. 1991 Sep-Oct 1
1619 1759920 Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus. 1991 Oct 2
1620 1773025 Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). 1991 2
1621 1788832 Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugs. 1991 Nov 15 1
1622 1834486 The insulin sparing effect of metformin in insulin-treated diabetic patients. 1991 May 3
1623 1900072 Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. 1991 Feb 3
1624 1916049 Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. 1991 Jul 2
1625 1936473 Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. 1991 May 1
1626 1936475 Management of type 2 diabetes mellitus with special reference to metformin therapy. 1991 May 3
1627 1936478 Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. 1991 May 5
1628 1936479 Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes. 1991 May 1
1629 1936485 BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance. 1991 May 2
1630 1955512 Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. 1991 Dec 1
1631 2086278 Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients. 1990 Dec 3
1632 2191888 Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. 1990 Jul 1
1633 2198745 Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. 1990 Apr-Jun 2
1634 2258095 [Bedtime administration of metformin may reduce insulin requirements]. 1990 Oct 1
1635 2523787 The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes. 1989 Apr 1
1636 2648723 Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. 1989 Mar 2
1637 2702918 Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics. 1989 Jan 3 1
1638 3075902 Treatment--metformin. 1988 May 2
1639 3149105 Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy. 1988 Jul-Sep 1
1640 3239906 [Lipoatrophic diabetes with insulin resistance controlled by metformin]. 1988 1
1641 3115843 Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. 1987 Jul 3
1642 3126223 Effects of metformin and glibenclamide on insulin receptors in fibroblasts and tumor cells in vitro. 1987 Dec 5
1643 3310318 Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. 1987 Jun 3 1
1644 3329125 [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. 1987 Nov-Dec 1
1645 3552509 Role of metformin in treatment of diabetes mellitus. 1987 Jan-Feb 3
1646 3552515 Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 1987 Jan-Feb 5
1647 3552772 Metformin enhances insulin binding to "in vitro" down regulated human fat cells. 1987 Feb 9
1648 3552795 Mechanism of metformin action in non-insulin-dependent diabetes. 1987 May 1
1649 3533670 Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. 1986 Aug 3
1650 3745404 Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. 1986 Oct 2